You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Musculoskeletal conditions
  5. Arthritis

Golimumab for the treatment of rheumatoid arthritis after the failure of previous disease-modifying anti-rheumatic drugs

  • Technology appraisal guidance
  • Reference number: TA225
  • Published:  22 June 2011
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Response to consultee, commentator and public comments on the Appraisal Consultation Document (ACD)

Response to consultee, commentator and public comments on the Appraisal Consultation Document (ACD) Response to consultee, commentator and public comments on the Appraisal Consultation Document (ACD)
13 May 2011
(494.54 Kb 24 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 12 May 2011

Back to top